Skip to main content

Advertisement

SpringerLink
Log in

Rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis

  • Clinical Trials Report
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kallenberg CG, Zhao MH: Evolving concepts in pathogenesis and treatment of ANCA-associated systemic vasculitides. Nephrology 2009, 4:16–25.

    Google Scholar 

  2. Carruthers D, Sherlock J: Evidence-based management of ANCA vasculitis. Best Pract Res Clin Rheumatol 2009, 23:367–378.

    Article  PubMed  Google Scholar 

  3. Koukolaki M, Jayne DR: Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis. Nephron Clin Pract 2005, 102:100–107.

    Article  Google Scholar 

  4. Eleftheriou D, Melo M, Marks SD, et al.: Biologic therapy in primary systemic vasculitis of the young. Rheumatology 2009, June 17 (Epub ahead of print).

  5. De Groot K, Harpe L, Jayne DR et al.: Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 2009, 150:670–680.

    PubMed  Google Scholar 

  6. Brihaye B, Aouba A, Pagnoux C, et al.: Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener’s granulomatosis: a study on 8 patients. Clin Exp Rheumatol 2007, 25:S23–S27.

    CAS  PubMed  Google Scholar 

  7. Ferraro AJ, Smith SW, Neil D, Savage CO: Relapsed Wegener’s granulomatosis after rituximab therapy-B cells are present in new pathological lesions despite persistent “depletion” of peripheral blood. Nephron Dial Transplant 2008, 23:3030–3032.

    Article  Google Scholar 

  8. Keystone E, Fleischmann R, Emery P, et al.: Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis. Arthritis Rheum 2007, 56:3896–3908.

    Article  CAS  PubMed  Google Scholar 

  9. Hiemstra TF, Jayne DR: Newer therapies for vasculitis. Best Pract Res Clin Rheumatol 2008, 23:379–389.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, USA

    Luis R. Espinoza

  2. 1542 Tulane Avenue, New Orleans, LA, 70112, USA

    Luis R. Espinoza

Authors
  1. Luis R. Espinoza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luis R. Espinoza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Espinoza, L.R. Rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Curr Rheumatol Rep 11, 387–389 (2009). https://doi.org/10.1007/s11926-009-0068-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-009-0068-3

Keywords

Search

Navigation